Literature DB >> 25766219

Immunology. Getting sepsis therapy right.

Richard S Hotchkiss1, Edward R Sherwood2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25766219      PMCID： PMC4398343          DOI： 10.1126/science.aaa8334

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

1.  The search for effective therapy for sepsis: back to the drawing board?

Authors:  Derek C Angus
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

2.  The effect of age on the development and outcome of adult sepsis.

Authors:  Greg S Martin; David M Mannino; Marc Moss
Journal:  Crit Care Med       Date:  2006-01       Impact factor: 7.598

3.  Sepsis studies need new direction.

Authors:  Jonathan Cohen; Steven Opal; Thierry Calandra
Journal:  Lancet Infect Dis       Date:  2012-07       Impact factor: 25.071

4.  Sepsis biomarkers. Value and limitations.

Authors:  Jean-Louis Vincent; Larissa Teixeira
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

Review 5.  Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?

Authors:  Jenneke Leentjens; Matthijs Kox; Johannes G van der Hoeven; Mihai G Netea; Peter Pickkers
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

6.  Hospital deaths in patients with sepsis from 2 independent cohorts.

Authors:  Vincent Liu; Gabriel J Escobar; John D Greene; Jay Soule; Alan Whippy; Derek C Angus; Theodore J Iwashyna
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

7.  IL-7 restores lymphocyte functions in septic patients.

Authors:  Fabienne Venet; Anne-Perrine Foray; Astrid Villars-Méchin; Christophe Malcus; Françoise Poitevin-Later; Alain Lepape; Guillaume Monneret
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

8.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 9.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

10.  Reactivation of multiple viruses in patients with sepsis.

Authors:  Andrew H Walton; Jared T Muenzer; David Rasche; Jonathan S Boomer; Bryan Sato; Bernard H Brownstein; Alexandre Pachot; Terrence L Brooks; Elena Deych; William D Shannon; Jonathan M Green; Gregory A Storch; Richard S Hotchkiss
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240
View more
  54 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  miR-718 represses proinflammatory cytokine production through targeting phosphatase and tensin homolog (PTEN).

Authors:  Parisa Kalantari; Omid F Harandi; Sarika Agarwal; Florentina Rus; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Daniel R Caffrey; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

Review 3.  The intensive care medicine research agenda on septic shock.

Authors:  Anders Perner; Anthony C Gordon; Derek C Angus; Francois Lamontagne; Flavia Machado; James A Russell; Jean-Francois Timsit; John C Marshall; John Myburgh; Manu Shankar-Hari; Mervyn Singer
Journal:  Intensive Care Med       Date:  2017-05-12       Impact factor: 17.440

4.  Opening the Debate on the New Sepsis Definition. Precision Medicine: An Opportunity to Improve Outcomes of Patients with Sepsis.

Authors:  Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2016-07-15       Impact factor: 21.405

5.  The Cytokine Response to Lipopolysaccharide Does Not Predict the Host Response to Infection.

Authors:  Benjamin A Fensterheim; Yin Guo; Edward R Sherwood; Julia K Bohannon
Journal:  J Immunol       Date:  2017-03-08       Impact factor: 5.422

6.  Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie C Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Riad Lutfi; Shira Gertz; Jocelyn R Grunwell; Christopher J Lindsell
Journal:  Crit Care Med       Date:  2018-03       Impact factor: 7.598

Review 7.  Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

Authors:  Matthew J Delano; Peter A Ward
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 8.  Pathophysiology of septic shock: From bench to bedside.

Authors:  Kevin W McConnell; Craig M Coopersmith
Journal:  Presse Med       Date:  2016-04-13       Impact factor: 1.228

9.  Three Data-Driven Phenotypes of Multiple Organ Dysfunction Syndrome Preserved from Early Childhood to Middle Adulthood.

Authors:  Jiancheng Ye; L Nelson Sanchez-Pinto
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 10.  Using cultured endothelial cells to study endothelial barrier dysfunction: Challenges and opportunities.

Authors:  Jurjan Aman; Ester M Weijers; Geerten P van Nieuw Amerongen; Asrar B Malik; Victor W M van Hinsbergh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.